McKesson Corporation (NYSE:MCK) has received a consensus recommendation of “Buy” from the twenty-one ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $174.31.

Several brokerages recently issued reports on MCK. Morgan Stanley cut McKesson from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $184.00 to $172.00 in a research note on Thursday, September 14th. BidaskClub cut McKesson from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Needham & Company LLC upgraded McKesson from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a research note on Friday, September 8th. Mizuho set a $168.00 price target on McKesson and gave the company a “hold” rating in a research note on Tuesday, October 24th. Finally, Royal Bank Of Canada began coverage on McKesson in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $168.00 price target for the company.

Shares of McKesson (NYSE MCK) traded down $1.35 during trading hours on Friday, hitting $146.39. The stock had a trading volume of 2,560,700 shares, compared to its average volume of 1,880,070. McKesson has a 12 month low of $133.82 and a 12 month high of $169.29. The company has a market capitalization of $31,920.00, a PE ratio of 12.04, a PEG ratio of 1.50 and a beta of 1.23. The company has a current ratio of 1.05, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, October 26th. The company reported $3.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.78 by $0.50. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.69 billion. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the previous year, the company posted $2.94 earnings per share. analysts forecast that McKesson will post 12.16 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend is Thursday, November 30th. McKesson’s payout ratio is presently 6.44%.

In other McKesson news, CEO John H. Hammergren sold 99,000 shares of the company’s stock in a transaction on Friday, September 29th. The stock was sold at an average price of $153.89, for a total transaction of $15,235,110.00. Following the completion of the sale, the chief executive officer now directly owns 165,000 shares in the company, valued at $25,391,850. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO John H. Hammergren sold 100,000 shares of the company’s stock in a transaction on Thursday, September 28th. The stock was sold at an average price of $153.51, for a total transaction of $15,351,000.00. Following the transaction, the chief executive officer now owns 165,000 shares of the company’s stock, valued at $25,329,150. The disclosure for this sale can be found here. Insiders have sold 949,900 shares of company stock valued at $145,403,445 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.

Large investors have recently made changes to their positions in the company. Ingalls & Snyder LLC increased its holdings in shares of McKesson by 76.7% during the third quarter. Ingalls & Snyder LLC now owns 16,939 shares of the company’s stock worth $2,602,000 after buying an additional 7,352 shares in the last quarter. Whittier Trust Co. increased its holdings in shares of McKesson by 1.5% during the third quarter. Whittier Trust Co. now owns 62,812 shares of the company’s stock worth $9,649,000 after buying an additional 898 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of McKesson by 12.7% during the second quarter. Wells Fargo & Company MN now owns 2,121,171 shares of the company’s stock worth $349,017,000 after buying an additional 239,358 shares in the last quarter. River & Mercantile Asset Management LLP increased its holdings in shares of McKesson by 278.6% during the third quarter. River & Mercantile Asset Management LLP now owns 177,824 shares of the company’s stock worth $27,321,000 after buying an additional 130,852 shares in the last quarter. Finally, Dai Ichi Life Insurance Company Ltd increased its holdings in shares of McKesson by 194.3% during the second quarter. Dai Ichi Life Insurance Company Ltd now owns 29,462 shares of the company’s stock worth $4,848,000 after buying an additional 19,450 shares in the last quarter. Institutional investors own 88.10% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “McKesson Corporation (MCK) Receives $174.27 Consensus Price Target from Analysts” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/12/04/mckesson-corporation-mck-receives-174-27-consensus-price-target-from-analysts.html.

McKesson Company Profile

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Analyst Recommendations for McKesson (NYSE:MCK)

Receive News & Stock Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related stocks with our FREE daily email newsletter.